Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 9254907, 6 pages
http://dx.doi.org/10.1155/2016/9254907
Research Article

The First Outbreak Caused by Acinetobacter baumannii ST208 and ST195 in China

1Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu 610041, China
2Intensive Care Unit, No. 4 West China Teaching Hospital, Sichuan University, Chengdu 610041, China

Received 4 December 2015; Revised 25 February 2016; Accepted 17 March 2016

Academic Editor: Wejdene Mansour

Copyright © 2016 Junyan Qu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Y. Peleg, H. Seifert, and D. L. Paterson, “Acinetobacter baumannii: emergence of a successful pathogen,” Clinical Microbiology Reviews, vol. 21, no. 3, pp. 538–582, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. V. Villegas and A. I. Hartstein, “Acinetobacter outbreaks, 1977–2000,” Infection Control and Hospital Epidemiology, vol. 24, no. 4, pp. 284–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Garnacho-Montero, C. Ortiz-Leyba, E. Fernández-Hinojosa et al., “Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings,” Intensive Care Medicine, vol. 31, no. 5, pp. 649–655, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Livermore, “The impact of carbapenemases on antimicrobial development and therapy,” Current Opinion in Investigational Drugs, vol. 3, no. 2, pp. 218–224, 2002. View at Google Scholar · View at Scopus
  5. L. Dijkshoorn, A. Nemec, and H. Seifert, “An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii,” Nature Reviews Microbiology, vol. 5, no. 12, pp. 939–951, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Vikas, S. Sinha, and N. P. Singh, “Multidrug resistant acinetobacter,” Journal of Global Infectious Diseases, vol. 2, no. 3, pp. 291–304, 2010. View at Publisher · View at Google Scholar
  7. A. N. Sari, M. Biçmen, and Z. Gülay, “The first report on the outbreak of OXA-24/40-like carbapenemase-producing Acinetobacter baumannii in Turkey,” Japanese Journal of Infectious Diseases, vol. 66, no. 5, pp. 439–442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. H. Kim, J.-Y. Choi, H. W. Kim et al., “Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 11, pp. 5239–5246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Merino, M. Poza, I. Roca et al., “Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain,” Microbial Drug Resistance, vol. 20, no. 4, pp. 259–263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Garlantézec, C. Bourigault, J.-M. Boles et al., “Investigation and management of an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak in an intensive care unit,” Medecine et Maladies Infectieuses, vol. 41, no. 8, pp. 430–436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kohlenberg, S. Brümmer, P. G. Higgins et al., “Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre,” Journal of Medical Microbiology, vol. 58, no. 11, pp. 1499–1507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Ruan, Y. Chen, Y. Jiang et al., “Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China,” International Journal of Antimicrobial Agents, vol. 42, no. 4, pp. 322–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Wang, F. Qiao, R. Yu, Y. Gao, and Z. Zong, “Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study,” BMC Microbiology, vol. 13, article 234, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Deng, M.-H. Zhu, J.-J. Li et al., “Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 1, pp. 297–303, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Clinical and Laboratory Standards Institute (CLSI), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 9th edition, 2012.
  16. J.-W. Liu, T.-N. Jang, Y.-J. Cheng et al., “Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan,” International Journal of Antimicrobial Agents, vol. 35, no. 2, pp. 201–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Woodford, M. J. Ellington, J. M. Coelho et al., “Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.,” International Journal of Antimicrobial Agents, vol. 27, no. 4, pp. 351–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. G. Higgins, M. Lehmann, and H. Seifert, “Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.,” International Journal of Antimicrobial Agents, vol. 35, no. 3, p. 305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Ellington, J. Kistler, D. M. Livermore, and N. Woodford, “Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 2, pp. 321–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Poirel, I. Le Thomas, T. Naas, A. Karim, and P. Nordmann, “Biochemical sequence analyses of GES-1, a novel class A extended- spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 3, pp. 622–632, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. P. A. Bradford, S. Bratu, C. Urban et al., “Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City,” Clinical Infectious Diseases, vol. 39, no. 1, pp. 55–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Seifert, L. Dolzani, R. Bressan et al., “Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii,” Journal of Clinical Microbiology, vol. 43, no. 9, pp. 4328–4335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. F. C. Tenover, R. D. Arbeit, R. V. Goering et al., “Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing,” Journal of Clinical Microbiology, vol. 33, no. 9, pp. 2233–2239, 1995. View at Google Scholar
  24. S. G. Bartual, H. Seifert, C. Hippler, M. A. D. Luzon, H. Wisplinghoff, and F. Rodríguez-Valera, “Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii,” Journal of Clinical Microbiology, vol. 43, no. 9, pp. 4382–4390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Adams-Haduch, E. O. Onuoha, T. Bogdanovich et al., “Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States,” Journal of Clinical Microbiology, vol. 49, no. 11, pp. 3849–3854, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Y.-Y. Tan, S. L. Chua, Y. Liu et al., “Comparative genomic analysis of rapid evolution of an extreme-drug-resistant Acinetobacter baumannii clone,” Genome Biology and Evolution, vol. 5, no. 5, pp. 807–818, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Tada, T. Miyoshi-Akiyama, K. Shimada, M. Shimojima, and T. Kirikae, “Dissemination of 16s rrna methylase arma-producing Acinetobacter baumannii and emergence of oxa-72 carbapenemase coproducers in Japan,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 5, pp. 2916–2920, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Zhou, Q. Yang, Y.-S. Yu, Z.-Q. Wei, and L.-J. Li, “Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China,” Journal of Clinical Microbiology, vol. 45, no. 12, pp. 4054–4057, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Wang, Z. Zong, and X. Lü, “Tn2008 is a major vehicle carrying blaOXA-23 in Acinetobacter baumannii from China,” Diagnostic Microbiology and Infectious Disease, vol. 69, no. 2, pp. 218–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. T. W. Boo and B. Crowley, “Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned?” Journal of Medical Microbiology, vol. 58, no. 6, pp. 839–841, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. F. Turton, M. E. Ward, N. Woodford et al., “The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii,” FEMS Microbiology Letters, vol. 258, no. 1, pp. 72–77, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Hamouda, B. A. Evans, K. J. Towner, and S. G. B. Amyes, “Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes,” Journal of Clinical Microbiology, vol. 48, no. 7, pp. 2476–2483, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. C. Rodloff, R. Leclercq, E. A. Debbia, R. Cantón, B. A. Oppenheim, and M. J. Dowzicky, “Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial,” Clinical Microbiology and Infection, vol. 14, no. 4, pp. 307–314, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. L. Maragakis and T. M. Perl, “Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options,” Clinical Infectious Diseases, vol. 46, no. 8, pp. 1254–1263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Pittet, S. Hugonnet, S. Harbarth et al., “Effectiveness of a hospital-wide programme to improve compliance with hand hygiene,” The Lancet, vol. 356, no. 9238, pp. 1307–1312, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. M. P. D. Deege and D. L. Paterson, “Reducing the development of antibiotic resistance in critical care units,” Current Pharmaceutical Biotechnology, vol. 12, no. 12, pp. 2062–2069, 2011. View at Publisher · View at Google Scholar · View at Scopus